PTGXProtagonist Therapeutics

Median target
$171.5
calls from the last 12 months
Implied return
+19.3%
median target vs. price
Coverage
13 analysts · 15 calls
updated in the last 12 months
Consensus
13/0/0+13 net
Buy / Hold / Sell

Which analysts are behind PTGX's consensus?

See every current rating, price target and the analysts' track records for Protagonist Therapeutics — plus the full analyst rankings, firm analytics and screener.

The consensus above reflects 13 analysts with calls on PTGX updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.

PTGX elsewhere on AnalystEdge

The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.

Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)

DateSourceWhoActionDetailAmount
2026-09-10InsidersPatel Dinesh V Ph DPresident and CEOInsider sale7.3K sh @ $144.10 · planned trade$1.0M
2026-09-09InsidersPatel Dinesh V Ph DPresident and CEOInsider sale63.5K sh @ $146.18 · planned trade$9.3M
2026-09-08InsidersPatel Dinesh V Ph DPresident and CEOInsider sale54.2K sh @ $145.87 · planned trade$7.9M
2026-08-11InsidersPatel Dinesh V Ph DPresident and CEOInsider sale34.2K sh @ $148.52 · planned trade$5.1M
2026-08-10InsidersPatel Dinesh V Ph DPresident and CEOInsider sale65.8K sh @ $149.11 · planned trade$9.8M
2025-10-16ExecutiveTrump, Donald JPresidentSaleProtagonist Therapeutics, Inc$1,001 - $1,500,010
2025-07-31ExecutiveTrump, Donald JPresidentPurchaseProtagonist Therapeutics, Inc$15,001 - $500,007
2025-05-29ExecutiveTrump, Donald JPresidentSaleProtagonist Therapeutics, Inc$1,001 - $150,005
2025-05-15ExecutiveTrump, Donald JPresidentPurchaseProtagonist Therapeutics, Inc$15,001 - $500,005
2025-02-24ExecutiveTrump, Donald JPresidentPurchaseProtagonist Therapeutics, Inc$1,001 - $150,002

More: insider activity · executive branch · trending